Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit ...

Senti Bio to Present at the 2025 Synthetic Biology: Engineering, Evolution, & Design (SEED) Conference Provided by GlobeNewswire Jun 24, 2025, 5:45:00 AM ...

Accelerating Gene Design, Strain Optimization, and Bioprocess Control for Next-Generation Biomanufacturing We are committed to advancing synthetic biology through the power of AI... BioSynthAI™’s ...

Hybrid biology-based semiconductor electronic systems are within the realm of possibility. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-58030-y ...

Founded in 2021, Syntec Bio is a UK-based biotechnology company developing carbon-neutral bio-production technologies to replace high-emission industrial systems. Its proprietary SynFermentTM platform ...

Access the segment here SOUTH SAN FRANCISCO, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company ...

The Korvaa Consortium tapped Modern Synthesis, Ecovative and Ourobio to develop the debut shoe made with mycelium, bacterial ...

Imagine printing your Martian home from dust, sunlight, and a bit of biology. A new synthetic lichen system uses fungi and bacteria to grow building materials directly from Martian soil, completely ...

According to CEC Capital Group's projections, China's bio-manufacturing market is expected to reach 2 trillion yuan (279 billion U.S. dollars) by 2033, with a robust 16.6 percent compound annual ...